Feng Chen

5.3k total citations
207 papers, 3.4k citations indexed

About

Feng Chen is a scholar working on Psychiatry and Mental health, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Feng Chen has authored 207 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Psychiatry and Mental health, 39 papers in Molecular Biology and 39 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Feng Chen's work include Epilepsy research and treatment (23 papers), Pharmacological Effects and Toxicity Studies (21 papers) and Pharmacological Effects of Natural Compounds (17 papers). Feng Chen is often cited by papers focused on Epilepsy research and treatment (23 papers), Pharmacological Effects and Toxicity Studies (21 papers) and Pharmacological Effects of Natural Compounds (17 papers). Feng Chen collaborates with scholars based in China, United States and Canada. Feng Chen's co-authors include Hong‐Li Guo, Ya‐Hui Hu, Jing Xu, Gregg Henderson, Betty C. R. Zhu, Roger A. Laine, Ke Yu, Chuan Li, Hai-Long Li and Michael S. Pratte and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Feng Chen

186 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Chen China 29 871 556 482 285 283 207 3.4k
Anne Marie Minihane United Kingdom 57 2.0k 2.3× 212 0.4× 487 1.0× 268 0.9× 229 0.8× 192 9.9k
Mushtaq Ahmad Ansari Saudi Arabia 42 1.4k 1.6× 414 0.7× 416 0.9× 494 1.7× 71 0.3× 200 4.7k
Yue Liu China 43 2.3k 2.7× 452 0.8× 326 0.7× 160 0.6× 156 0.6× 323 6.5k
Sheikh F. Ahmad Saudi Arabia 47 2.0k 2.3× 510 0.9× 400 0.8× 855 3.0× 119 0.4× 298 6.4k
George L. Tipoe Hong Kong 45 1.6k 1.9× 550 1.0× 434 0.9× 138 0.5× 117 0.4× 174 6.4k
Jingwen Wang China 30 1.3k 1.5× 227 0.4× 312 0.6× 154 0.5× 78 0.3× 191 3.4k
An Vermeulen Belgium 35 905 1.0× 289 0.5× 569 1.2× 100 0.4× 429 1.5× 222 5.0k
Ali I. Al‐Gareeb Iraq 45 2.0k 2.3× 332 0.6× 236 0.5× 76 0.3× 126 0.4× 352 6.9k
Ruisheng Li China 41 1.6k 1.8× 876 1.6× 402 0.8× 79 0.3× 96 0.3× 188 4.7k
Hayder M. Al‐kuraishy Iraq 46 2.1k 2.4× 346 0.6× 239 0.5× 79 0.3× 130 0.5× 369 7.2k

Countries citing papers authored by Feng Chen

Since Specialization
Citations

This map shows the geographic impact of Feng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Chen more than expected).

Fields of papers citing papers by Feng Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Chen. The network helps show where Feng Chen may publish in the future.

Co-authorship network of co-authors of Feng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Chen. A scholar is included among the top collaborators of Feng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Chen. Feng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Hong‐Li, Na Dong, Ya‐Hui Hu, et al.. (2025). Serum HDL-C levels in children with epilepsy: a single-center retrospective study. Frontiers in Nutrition. 12. 1523426–1523426. 1 indexed citations
2.
Kow, Chia Siang, et al.. (2025). Bleeding risk assessment tools in patients with atrial fibrillation taking anticoagulants: a comparative review and clinical implications. Expert Review of Cardiovascular Therapy. 23(6). 303–315. 1 indexed citations
3.
Lv, Wang, Feng Chen, Tianyi Tan, et al.. (2025). Smart-SNPer: Automated crRNA design for ultrasensitive RPA-Cas12a SNP detection. Biosensors and Bioelectronics. 289. 117909–117909.
4.
Qiu, Long, et al.. (2025). Orientin attenuates UVB-induced skin photodamage by inhibiting ROS generation via the AMPK/Nrf2 axis. International Immunopharmacology. 155. 114655–114655. 3 indexed citations
5.
Du, Zepeng, Jiajun Li, Yi Wang, et al.. (2025). Integrative causal inference illuminates gene-environment interactions linking endocrine disruptors to female infertility. Ecotoxicology and Environmental Safety. 302. 118679–118679. 1 indexed citations
6.
7.
Liu, Yun, Hong‐Li Guo, Keyu Lu, et al.. (2024). A small step toward precision dosing of caffeine in preterm infants: An external evaluation of published population pharmacokinetic models. European Journal of Pharmaceutics and Biopharmaceutics. 204. 114484–114484.
8.
Wang, Jie, Weijun Wang, Jian Huang, et al.. (2024). CYP2C19 genotype and sodium channel blockers in lacosamide-treated children with epilepsy: two major determinants of trough lacosamide concentration or clinical response. Therapeutic Advances in Neurological Disorders. 17. 4233554175–4233554175. 1 indexed citations
9.
10.
Wang, Weijun, Ya‐Hui Hu, Jie Wang, et al.. (2024). Population pharmacokinetics of valproic acid in children with epilepsy: Implications for dose tailoring when switching from oral syrup to sustained‐release tablets. CPT Pharmacometrics & Systems Pharmacology. 13(9). 1554–1569. 1 indexed citations
11.
Zeng, Yuanyuan, et al.. (2024). A novel scoring system based on sIL-2R for predicting IVIG resistance in Chinese children with KD. Pediatric Rheumatology. 22(1). 76–76.
12.
Guo, Hong‐Li, Jie Wang, Jian Huang, et al.. (2023). Effectiveness and safety of mono‐ and add‐on perampanel in pediatric patients with epilepsy: Experience from a single‐center retrospective study. Epilepsia Open. 9(1). 268–277. 3 indexed citations
13.
Guo, Hong‐Li, Weijun Wang, Jie Wang, et al.. (2023). Integrating metabolomics and lipidomics revealed a decrease in plasma fatty acids but an increase in triglycerides in children with drug‐refractory epilepsy. Epilepsia Open. 8(2). 466–478. 15 indexed citations
14.
Zhao, Yinglan, et al.. (2023). Early warning of exchange rate risk based on structural shocks in international oil prices using the LSTM neural network model. Energy Economics. 126. 106921–106921. 7 indexed citations
15.
Hu, Ya‐Hui, Hong‐Li Guo, Yuanyuan Zhang, et al.. (2022). Therapeutic drug monitoring of perampanel in children diagnosed with epilepsy: Focus on influencing factors on the plasma concentration‐to‐dose ratio. Epilepsia Open. 7(4). 737–746. 13 indexed citations
16.
Sun, Jieyu, Zejun Xu, Fang Sun, et al.. (2018). Individualized Tacrolimus Therapy for Pediatric Nephrotic Syndrome: Considerations for Ontogeny and Pharmacogenetics of CYP3A. Current Pharmaceutical Design. 24(24). 2765–2773. 16 indexed citations
17.
Yuan, Ye, Ying Tan, Peng Xu, et al.. (2014). Izalpinin from fruits of <i>Alpinia oxyphylla</i> with antagonistic activity against the rat bladder contractility. African Journal of Traditional Complementary and Alternative Medicines. 11(4). 120–120. 12 indexed citations
18.
Su, Qiao, et al.. (2008). Role of Young Scientists in the Emergency Response and Scientific Investigation Related to the 2008 Wenchuan Earthquake: Performance Evaluation and Discussion on the Implications to Seismological Education and Training. AGUFM. 2008. 1 indexed citations
19.
Chen, Feng. (2008). On proper volume of different fluids for hemorrhagic shock resuscitation in rats. Di-san junyi daxue xuebao.
20.
Chen, Feng, et al.. (2007). A multicenter, randomized, double-blinded and placebo-controlled study of acute brain infarction treated by human urinary kallidinogenase. 40(5). 306–310. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Marie Minihane Breakdown of academic impact, for papers by Mushtaq Ahmad Ansari Breakdown of academic impact, for papers by Yue Liu Breakdown of academic impact, for papers by Sheikh F. Ahmad Breakdown of academic impact, for papers by George L. Tipoe Breakdown of academic impact, for papers by Jingwen Wang Breakdown of academic impact, for papers by An Vermeulen Breakdown of academic impact, for papers by Ali I. Al‐Gareeb Breakdown of academic impact, for papers by Ruisheng Li Breakdown of academic impact, for papers by Hayder M. Al‐kuraishy
Rankless by CCL
2026